tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joel Beatty, 65 are a HOLD (16.37%), 7 are a SELL (1.76%), 325 are a BUY (81.86%).
Analyst Joel Beatty, currently employed at BAIRD, carries an average stock price target met ratio of 61.66% that have a potential upside of 49.48% achieved within 345 days.
Joel Beatty’s has documented 760 price targets and ratings displayed on 79 stocks. The coverage is on Healthcare, Consumer Defensive, Energy, Industrials sectors.
Most recent stock forecast was given on RARE, Ultragenyx at 03-Sep-2026.
Analyst best performing recommendations are on NK (NANTKWEST).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA AMERICAN DEPOSITARY SHARES) at 3/3/2023. The price target of $11 was fulfilled within 3 days with a profit of $4.57 (71.07%) receiving and performance score of 236.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Mar-2025
$318
$69.32 (27.88%)
$380
24 days ago
(19-Aug-2026)
33/36 (91.67%)
$75.39 (31.07%)
270
Hold Since 20-Oct-2025
$256
$7.32 (2.94%)
$316
29 days ago
(14-Aug-2026)
2/6 (33.33%)
$27.35 (11.96%)
38
Buy Since 21-Jul-2025
$315
$66.32 (26.67%)
$410
1 months 8 days ago
(04-Aug-2026)
4/9 (44.44%)
$96 (43.84%)
11
Buy Since 29-Jul-2025
$420
$171.32 (68.89%)
$472
1 months 9 days ago
(03-Aug-2026)
4/5 (80%)
$199.67 (90.62%)
19
Buy Since 28-Jun-2024
$450
$201.32 (80.96%)
$527
1 months 9 days ago
(03-Aug-2026)
1/3 (33.33%)
$229.67 (104.24%)
110
Which stock is Joel Beatty most bullish on?
Which stock is Joel Beatty most reserved on?
What Year was the first public recommendation made by Joel Beatty?
